BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16677597)

  • 1. Colposcopy at a crossroads.
    Jeronimo J; Schiffman M
    Am J Obstet Gynecol; 2006 Aug; 195(2):349-53. PubMed ID: 16677597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
    Walker JL; Wang SS; Schiffman M; Solomon D;
    Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy compared with human papilloma virus testing (Hybrid Capture II) and conventional cervical cytology as a primary screening test for cervical high-grade lesions and cancer in 1555 patients with biopsy confirmation.
    Guillaud M; Benedet JL; Cantor SB; Staerkel G; Follen M; MacAulay C
    Cancer; 2006 Jul; 107(2):309-18. PubMed ID: 16773634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia.
    Berry JM; Palefsky JM; Jay N; Cheng SC; Darragh TM; Chin-Hong PV
    Dis Colon Rectum; 2009 Feb; 52(2):239-47. PubMed ID: 19279418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colposcopy, cervical screening, and HPV. Preface.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):xv-xvi. PubMed ID: 19061813
    [No Abstract]   [Full Text] [Related]  

  • 9. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
    Wheeler CM
    Nat Clin Pract Oncol; 2007 Apr; 4(4):224-35. PubMed ID: 17392713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment.
    Ronco G; Brezzi S; Carozzi F; Dalla Palma P; Giorgi-Rossi P; Minucci D; Naldoni C; Segnan N; Zappa M; Zorzi M; Cuzick J;
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S230-2. PubMed ID: 17822751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
    Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
    Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of high-risk HPV-DNA testing in the male sexual partners of women with HPV-induced lesions.
    Giraldo PC; Eleutério J; Cavalcante DI; Gonçalves AK; Romão JA; Eleutério RM
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):88-91. PubMed ID: 17485158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
    Lie AK; Kristensen G
    Expert Rev Mol Diagn; 2008 Jul; 8(4):405-15. PubMed ID: 18598223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance.
    Fletcher AH; Wilkinson EJ; Knapik JA
    J Low Genit Tract Dis; 2009 Jan; 13(1):28-32. PubMed ID: 19098603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary report on the application of colposcopy in screening of cervical carcinoma].
    Zhang WH; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 1994 Jan; 16(1):59-62. PubMed ID: 8033752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Integrating HPV testing for primary screening?].
    Riethmuller D; Ramanah R; Pretet JL; Mougin C
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing new technologies for cervical cancer screening: beyond sensitivity.
    Massad LS
    J Low Genit Tract Dis; 2008 Oct; 12(4):311-5. PubMed ID: 18820547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chapter 10: New dimensions in cervical cancer screening.
    Cuzick J; Mayrand MH; Ronco G; Snijders P; Wardle J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/90-7. PubMed ID: 16950022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.